[1] Bloem B R, Okun M S, Klein C. Parkinson's disease[J]. Lancet, 2021, 397(10291): 2284-2303. [2] Guo X Y, Ma T. Effects of acupuncture on neurological disease in clinical- and animal-based research[J]. Front Integr Neurosci, 2019, 13: 47. [3] Zhao Y D, Zhang Z C, Qin S R, et al. Acupuncture for Parkinson's disease: efficacy evaluation and mechanisms in the dopaminergic neural circuit[J]. Neural Plast, 2021, 2021: 9926445. [4] Liang X B, Luo Y, Liu X Y, et al. Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats[J]. Neuroreport, 2003, 14(8): 1177-1181. [5] Wang H M, Pan Y L, Xue B, et al. The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease[J]. Plos One, 2011, 6(5): e19790. [6] Jia J, Sun Z L, Li B, et al. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats[J]. Behav Brain Res, 2009, 205(1): 214-218. [7] Lv E, Deng J, Yu Y, et al. Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease[J]. Free Radic Res, 2015, 49(11): 1296-1307. [8] Deng J H, Lv E, Yang J, et al. Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model[J]. J Neuroinflammation, 2015, 12: 103. [9] Yu Y, Wang K, Deng J H, et al. Electroacupuncture produces the sustained motor improvement in 6-hydroxydopamine-lesioned mice[J]. Plos One, 2016, 11(2): e0149111. [10] Jia Y J, Deng J H, Zhang W Z, et al. The role of group II metabotropic glutamate receptors in the striatum in electroacupuncture treatment of Parkinsonian rats[J]. CNS Neurosci Ther, 2017, 23(1): 23-32. [11] Li M, Li L J, Wang K, et al. The effect of electroacupuncture on proteomic changes in the motor cortex of 6-OHDA Parkinsonian rats[J]. Brain Res, 2017, 1673: 52-63. [12] Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat[J]. J Comp Neurol, 1990, 296(4): 517-530. [13] 李莉,余剑波,刘志学. 针刺镇痛与c-fos基因的研究[J]. 临床麻醉学杂志, 2011, 27(10): 1030-1032. [14] 于燕,王可,贾军,等. 纹状体注射不同剂量6-OHDA制备帕金森病小鼠模型的评价[J]. 首都医科大学学报, 2015, 36(2): 255-261. [15] DeLong M R. Primate models of movement disorders of basal ganglia origin[J]. Trends Neurosci, 1990, 13(7): 281-285. [16] Meoni S, Cury R G, Moro E. New players in basal ganglia dysfunction in Parkinson's disease[J]. Prog Brain Res, 2020, 252: 307-327. [17] Fieblinger T. Striatal control of movement: a role for new neuronal (sub-) populations?[J]. Front Hum Neurosci, 2021, 15: 697284. [18] 张辉,马惠清,王森茂,等. 银杏叶提取物对帕金森病模型大鼠脑内神经炎性反应的影响[J]. 首都医科大学学报, 2019, 40(3): 439-442. [19] Cao L J, Li X X, Li M X, et al. The effectiveness of acupuncture for Parkinson’s disease: an overview of systematic reviews[J]. Complement Ther Med, 2020, 50: 102383. [20] Lee S H, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: a PRISMA-compliant systematic review and meta-analysis[J]. Medicine, 2017, 96(3): e5836. [21] Ye Q P, Liu C Y, Shi J H, et al. Effect of electro-acupuncture on regulating the swallowing by activating the interneuron in ventrolateral medulla (VLM)[J]. Brain Res Bull, 2019, 144: 132-139. [22] Shi J H, Ye Q P, Zhao J Y, et al. EA promotes swallowing via activating swallowing-related motor neurons in the nucleus ambiguus[J]. Brain Res, 2019, 1718: 103-113. [23] 吴锋, 缪化春, 李怀斌. 电针下调氯胺酮滥用大鼠眶额叶皮质c-Fos、TH的表达[J]. 包头医学院学报, 2019, 35(1): 59-60. [24] 王强, 王渊, 牛文民, 等. 电针不同穴组对功能性腹泻大鼠下丘脑及结肠5-羟色胺和c-fos蛋白表达的影响[J]. 针刺研究, 2019, 44(7): 501-505. [25] Van Heukelum S, Mars R B, Guthrie M, et al. Where is cingulate cortex? A cross-species view[J]. Trends Neurosci, 2020, 43(5): 285-299. [26] 李德鹏, 徐群渊, 张进禄, 等. 大鼠PD模型多巴胺能神经元损毁与纹状体相关神经元内c-fos的表达[J]. 首都医科大学学报, 2000, 21(1): 16-19. [27] Wang Y, Yao L, Gao S S, et al. Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson’s disease[J]. Brain Res, 2021, 1754: 147266. [28] Gomez G, Escande M V, Suarez L M, et al. Changes in dendritic spine density and inhibitory perisomatic connectivity onto medium spiny neurons in L-dopa-induced dyskinesia[J]. Mol Neurobiol, 2019, 56(9): 6261-6275. |